Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 5, 2013, Pages 1163-1171

  Amicizia, Daniela ^a   Domnich, Alexander ^a   Panatto, Donatella ^a   Lai, Piero Luigi ^a   Cristina, Maria Luisa ^a   Avio, Ulderico ^b   Gasparini, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Baxter SPA   (Italy)

Author keywords

Epidemiology; Prevention; Tbe vaccines; Tick borne encephalitis; Vaccine cross protection

Indexed keywords

ENCEVIR; TBE VACCINE MOSCOW; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

CROSS PROTECTION; EPIDEMIOLOGICAL DATA; EUROPE; HEALTH PROGRAM; HUMAN; NONHUMAN; REVIEW; TICK BORNE ENCEPHALITIS; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EPIDEMIOLOGY; PREVENTION; TBE VACCINES; TICK-BORNE ENCEPHALITIS; VACCINE CROSS-PROTECTION;

ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASES; EUROPE; HUMANS; VACCINATION; VIRAL VACCINES;

EID: 84878807980     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23802     Document Type: Review

References (116)

1. Schneider H. Über epidemische akute. Klin Wochenschr 1931; 44:350-2.
2. Silber LA, Soloviev VD. Far Eastern tick-borne spring-summer (spring) encephalitis. Am Rev Sov Med 1946; (Suppl):1-80; PMID:21002377.
3. Gallia F, Rampas J, Hollender L. Laboratory infection caused by tick-borne encephalitis virus. Cas Lek Cesk 1949; 88:224-9.
4. Süss J. Tick-borne encephalitis in Europe and beyond - the epidemiological situation as of 2007. Euro Surveill 2008; 13(26):pii=18916.
5. Süss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis 2011; 2:2-15; PMID:21771531; http://dx.doi.org/10.1016/j.ttbdis.2010.10.007.
6. Kunz C. Tick-borne encephalitis in Europe. Acta Leiden 1992; 60:1-14; PMID:1485492.
7. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 2008; 371:1861-71; PMID:18514730; http://dx.doi.org/10.1016/S0140-6736(08)60800-4.
8. Hansmann Y, Gut JP, Remy V, Martinot M, Christmanna D. TBE virus infection: clinical and epidemiological data. Med Mal Infect 2004; 34(Suppl 1):S28-30; PMID:15676240; http://dx.doi.org/10.1016/S0399-077X(04)90009-1.
9. Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T. Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol 2009; 90:1781-94; PMID:19420159; http://dx.doi.org/10.1099/vir.0.011437-0.
10. Lindenbach BD, Rice CA. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th edition. London, New York and Tokyo: Lippincott Williams & Wilkins, 2001:991-1041.
11. Kollaritsch H, Krasilnikov V, Holzmann H, Karganova G, Barrett A, Suss J, et al. Background Document on Vaccines and Vaccination against Tick-borne Encephalitis (TBE). Available at: http://www.who.int/immunization/sage/6-TBE- backgr-18-Mar-net-apr-2011.pdf. January 3, 2013.
12. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis 1999; 28:882-90; PMID:10825054; http://dx.doi.org/10.1086/515195.
13. Sips GJ, Wilschut J, Smit JM. Neuroinvasive flavivirus infections. Rev Med Virol 2012; 22:69-87; PMID:22086854; http://dx.doi.org/10.1002/rmv.712.
14. International Committee on Taxonomy of Viruses. Virus Taxonomy: 2011 Release. Available at: http://www.ictvonline.org/virusTaxonomy. asp?version=2011&bhcp=1. Accessed: January 3, 2013.
15. Theiler M, Downs WG. The Arthropod-Borne Viruses of Vertebrates. New Haven: Yale University Press, 1973.
16. Calisher CH. Antigenic classification and taxonomy of flaviviruses (family Flaviviridae) emphasizing a universal system for the taxonomy of viruses causing tick-borne encephalitis. Acta Virol 1988; 32:469-78; PMID:2904743.
17. Demina TV, Dzhioev YP, Verkhozina MM, Kozlova IV, Tkachev SE, Plyusnin A, et al. Genotyping and characterization of the geographical distribution of tick-borne encephalitis virus variants with a set of molecular probes. J Med Virol 2010; 82:965-76; PMID:20419810; http://dx.doi.org/10.1002/jmv.21765.
18. Demina TV, Dzhioev IuP, Kozlova IV, Verkhozina MM, Tkachev SE, Doroshchenko EK, et al. Genotypes 4 and 5 of the tick-borne encephalitis virus: features of the genome structure and possible scenario for its formation. Vopr Virusol 2012; 57:13-9; PMID:23012978.
19. World Health Organization (WHO). Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec 2011; 86:241-56; PMID:21661276.
20. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Available at: http://unstats.un.org/unsd/methods/m49/m49regin.htm. Accessed: January 3, 2013.
21. Žygutieṅ M. Tick-borne encephalitis - the most relevant to public health flavivirus infection in the EpiNorth region. EpiNorth 2011; 12:31-2.
22. Randolph SE. Tick-borne encephalitis incidence in Central and Eastern Europe: consequences of political transition. Microbes Infect 2008; 10:209-16; PMID:18316221; http://dx.doi.org/10.1016/j.micinf.2007.12.005.
23. Lundkvist k, Vene S, Golovljova I, Mavtchoutko V, Forsgren M, Kalnina V, et al. Characterization of tick-borne encephalitis virus from Latvia: evidence for co-circulation of three distinct subtypes. J Med Virol 2001; 65:730-5; PMID:11745938; http://dx.doi.org/10.1002/jmv.2097.
24. Jääskeläinen AE, Tikkakoski T, Uzcátegui NY, Alekseev AN, Vaheri A, Vapalahti O. Siberian subtype tickborne encephalitis virus, Finland. Emerg Infect Dis 2006; 12:1568-71; PMID:17176574; http://dx.doi.org/10.3201/eid1210.060320.
25. Donoso-Mantke O, Karan LS, Růžek D. Tick-Borne encephalitis Virus: A General Overview. In: Růžek D, eds. Flavivirus Encephalitis. Rijeka: InTech, 2011:133-56.
26. Nuttall PA, Jones LD, Labuda M, Kaufman WR. Adaptations of arboviruses to ticks. J Med Entomol 1994; 31:1-9; PMID:8158611.
27. Danielová V, Holubová J, Pejcoch M, Daniel M. Potential significance of transovarial transmission in the circulation of tick-borne encephalitis virus. Folia Parasitol (Praha) 2002; 49:323-5; PMID:12641208.
28. Waldenström J, Lundkvist A, Falk KI, Garpmo U, Bergström S, Lindegren G, et al. Migrating birds and tickborne encephalitis virus. Emerg Infect Dis 2007; 13:1215-8; PMID:17953095; http://dx.doi.org/10.3201/eid1308. 061416.
29. Movila A, Alekseev AN, Dubinina HV, Toderas I. Detection of tick-borne pathogens in ticks from migratory birds in the Baltic region of Russia. Med Vet Entomol 2012; In press; PMID:22924442; http://dx.doi.org/10.1111/j.1365-2915. 2012.01037.x.
30. Baxter. Tick-Borne Encephalitis (TBE, FSME). Monograph. Vienna: 2007. Available at: http://www.tbe-info.com/upload/medialibrary/Monograph-TBE.pdf. Accessed: January 3, 2013.
31. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 1999; 122:2067-78; PMID:10545392; http://dx.doi.org/10.1093/brain/122.11. 2067.
32. Kerbo N, Donchenko I, Kutsar K, Vasilenko V. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Euro Surveill 2005; 10:E050623.2.
33. Caini S, Szomor K, Ferenczi E, Szekelyne Gaspar A, Csohan A, Krisztalovics K, et al. Tick-borne encephalitis transmitted by unpasteurised cow milk in western Hungary, September to October 2011. Euro Surveill 2012; 17:pii:20128.
34. Gritsun TS, Lashkevich VA, Gould EA. Tickborne encephalitis. Antiviral Res 2003; 57:129-46; PMID:12615309; http://dx.doi.org/10.1016/S0166-3542(02) 00206-1.
35. Dobler G. Zoonotic tick-borne flaviviruses. Vet Microbiol 2010; 140:221-8; PMID:19765917; http://dx.doi.org/10.1016/j.vetmic.2009.08.024.
36. Kunze M, Kunze U. Social marketing and the establishment of the ISW-TBE. Vaccine 2003; 21(Suppl 1):S62-5; PMID:12628816; http://dx.doi.org/10.1016/S0264- 410X(02)00818-6.
37. Kunze U; ISW TBE. Conference report of the 10th meeting of the international scientific working group on tick-borne encephalitis (ISW-TBE): combating tick-borne encephalitis: vaccination rates on the rise. Vaccine 2008; 26:6738-40; PMID:19007838; http://dx.doi.org/10.1016/j.vaccine.2008.10.059.
38. Italian Ministry of Health. National Vaccine Plan 2012-2014. Available at: http://www.governoitaliano.it/backoffice/allegati/67507-7587.pdf. Accessed: January 3, 2013.
39. Tick-borne encephalitis incidence, the centralized information system for infectious diseases (CISID) - WHO. Available at: http://data.euro.who.int/ cisid/?TabID=290643. Accessed: January 3, 2013.
40. European Centre for Disease Prevention and Control. Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries. Stockholm: ECDC; 2012.
41. VENICE II. Tick-borne encephalitis surveillance systems and vaccination recommendations in UE/EEA, 2009. Collaboration between VENICE II project and ECDC. Available at: http://venice.cineca.org/final-report-TBE-19-01-2011.pdf. Accessed: January 3, 2013.
42. Lundkvist A, Wallensten A, Vene S, Hjertqvist M. Tick-borne encephalitis increasing in Sweden, 2011. Euro Surveill 2011; 16:pii=19981.
43. Incidence of Infectious and Parasitic Diseases in Ukraine in 2003. State Sanitary and Epidemiological Service of Ukraine. Available at: http://www.moz.gov.ua/ua/portal/pre-20040405-1.html. Accessed: January 3, 2013.
44. Donoso Mantke O, Escadafal C, Niedrig M, Pfeffer M, on behalf of the Working group for Tick-borne encephalitis virus. Tick-borne encephalitis in Europe, 2007 to 2009. Euro Surveill 2011; 16:pii:19979.
45. Amato-Gauci A, Zeller H. Tick-borne encephalitis joins the diseases under surveillance in the European Union. Euro Surveill 2012; 17(42):pii=20299.
46. Jaenson TG, Hjertqvist M, Bergström T, Lundkvist A. Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors 2012; 5:184; PMID:22937961; http://dx.doi.org/10.1186/1756-3305-5-184.
47. Jääskeläinen AE, Sironen T, Murueva GB, Subbotina N, Alekseev AN, Castrén J, et al. Tick-borne encephalitis virus in ticks in Finland, Russian Karelia and Buryatia. J Gen Virol 2010; 91:2706-12; PMID:20660147; http://dx.doi.org/10.1099/vir.0.023663-0.
48. Skarpaas T, Golovljova I, Vene S, Ljøstad U, Sjursen H, Plyusnin A, et al. Tickborne encephalitis virus, Norway and Denmark. Emerg Infect Dis 2006; 12:1136-8; PMID:16836835; http://dx.doi.org/10.3201/eid1207.051567.
49. Süss J. TBE - A Short Overview on Epidemiological Status in Europe. ISW-TBE 2012. Vienna, 2-3 February, 2012.
50. Kunz C. TBE vaccination and the Austrian experience. Vaccine 2003; 21(Suppl 1):S50-5; PMID:12628814; http://dx.doi.org/10.1016/S0264-410X(02)00813- 7.
51. Kunze U. Is there a need for a travel vaccination against tick-borne encephalitis? Travel Med Infect Dis 2008; 6:380-3; PMID:18984485; http://dx.doi.org/10.1016/j.tmaid.2008.06.004.
52. Dobler G, Gniel D, Petermann R, Pfeffer M. Epidemiology and distribution of tick-borne encephalitis. Wien Med Wochenschr 2012; 162:230-8; PMID:22699708; http://dx.doi.org/10.1007/s10354-012-0100-5.
53. Eurosurveillance Editorial team. Updated Risk areas for tick borne encephalitis in Germany. Euro Surveill 2009; 14(23):pii=19236.
54. Gäumann R, Růžek D, Mühlemann K, Strasser M, Beuret CM. Phylogenetic and virulence analysis of tickborne encephalitis virus field isolates from Switzerland. J Med Virol 2011; 83:853-63; PMID:21412794; http://dx.doi.org/10.1002/jmv.21993.
55. Petri E, Gniel D, Zent O. Tick-borne encephalitis (TBE) trends in epidemiology and current and future management. Travel Med Infect Dis 2010; 8:233-45; PMID:20970726; http://dx.doi.org/10.1016/j.tmaid.2010.08.001.
56. Collard M, Gut JP, Christmann D, Hirsch E, Nastorg G, Sellal F, et al. Tick-borne encephalitis in Alsace. Rev Neurol (Paris) 1993; 149:198-201; PMID:8235212.
57. Herpe B, Schuffenecker I, Pillot J, Malvy D, Clouzeau B, Bui N, et al. Tickborne encephalitis, southwestern France. Emerg Infect Dis 2007; 13:1114-6; PMID:18214196.
58. Šumilo D, Bormane A, Asokliene L, Lucenko I, Vasilenko V, Randolph S. Tick-borne encephalitis in the Baltic States: identifying risk factors in space and time. Int J Med Microbiol 2006; 296(Suppl 40):76-9; PMID:16530480; http://dx.doi.org/10.1016/j.ijmm.2005.12.006.
59. Karelis G, Bormane A, Logina I, Lucenko I, Suna N, Krumina A, et al. Tick-borne encephalitis in Latvia 1973-2009: epidemiology, clinical features and sequelae. Eur J Neurol 2012; 19:62-8; PMID:21615626; http://dx.doi.org/10.1111/ j.1468-1331.2011.03434.x.
60. Epstein E, Kutsar K. Epidemiological Trends of Tick-Borne Encephalitis in Estonia. EpiNorth 2009; 10:58-62.
61. nd International Scientific Conference "Tick-Borne Diseases", Vilnius, Lithuania, 12 April, 2012.
62. Jääskeläinen A, Korhonen T, Kuusi M, Vapalahti O. Tick-borne encephalitis in Finland. EpiNorth 2011; 12:40-3.
63. Andreassen A, Jore S, Cuber P, Dudman S, Tengs T, Isaksen K, et al. Prevalence of tick borne encephalitis virus in tick nymphs in relation to climatic factors on the southern coast of Norway. Parasit Vectors 2012; 5:177; PMID:22913287; http://dx.doi.org/10.1186/1756-3305-5-177.
64. Laursen K, Knudsen JD. Tick-borne encephalitis: a retrospective study of clinical cases in Bornholm, Denmark. Scand J Infect Dis 2003; 35:354-7; PMID:12875531; http://dx.doi.org/10.1080/00365540310005305.
65. Fomsgaard A, Christiansen CB, Bødker R. First identification of tick-borne encephalitis in Denmark outside of Bornholm, August 2009. Euro Surveill 2009; 14:pii=19325.
66. Grgiè-Vitek M, Klavs I. High burden of tick-borne encephalitis in Slovenia - challenge for vaccination policy. Vaccine 2011; 29:5178-83; PMID:21620916; http://dx.doi.org/10.1016/j.vaccine.2011.05.033.
67. Carpi G, Bertolotti L, Rosati S, Rizzoli A. Prevalence and genetic variability of tick-borne encephalitis virus in host-seeking Ixodes ricinus in northern Italy. J Gen Virol 2009; 90:2877-83; PMID:19675189; http://dx.doi.org/10.1099/vir.0.013367-0.
68. Rizzoli A, Hauffe HC, Tagliapietra V, Neteler M, Rosà R. Forest structure and roe deer abundance predict tick-borne encephalitis risk in Italy. PLoS One 2009; 4:e4336; PMID:19183811; http://dx.doi.org/10.1371/journal.pone. 0004336.
69. Molnár GB, Persecǎ T, Feder A, Pǎcuraru D, Marialaki E, Cojan A. Epidemiological assessment of morbidity and natural foci of TBE-CEE virus infection in Transylvania. Rev Med Chir Soc Med Nat Iasi 2008; 112:471-7; PMID:19295022.
70. Paduraru OA, Buffet JP, Cote M, Bonnet S, Moutailler S, Paduraru V, et al. Zoonotic transmission of pathogens by Ixodes ricinus ticks, Romania. Emerg Infect Dis 2012; 18:2089-90; PMID:23171510; http://dx.doi.org/10.3201/eid1812. 120711.
71. Pavlidou V, Geroy S, Diza E, Antoniadis A, Papa A. Epidemiological study of tick-borne encephalitis virus in northern Greece. Vector Borne Zoonotic Dis 2007; 7:611-5; PMID:18171108; http://dx.doi.org/10.1089/vbz.2007.0107.
72. Kollaritsch H, Chmelík V, Dontsenko I, Grzeszczuk A, Kondrusik M, Usonis V, et al. The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: report from a meeting of experts convened to discuss TBE in their region. Vaccine 2011; 29:4556-64; PMID:21549781; http://dx.doi.org/10.1016/j.vaccine.2011.04.061.
73. Stefanoff P, Rogalska J, Zajkowska J, Czerska M, Seroka W, Czarkowski MP. Surveillance of aseptic central nervous system infections in Poland: is it meeting its objectives? Euro Surveill 2011; 16:pii=19924.
74. Karaban I, Vedenkov A, Yashkova S, Sebut N. Epidemiology of tick-borne encephalitis and Lyme disease in the Republic of Belarus, 1998-2007. EpiNorth 2009; 10:48-57.
75. Federal service on customers' rights protection and human well-being surveillance. Tick-borne encephalitis. Available at: http://rospotrebnadzor.ru/ c/journal/view-content?groupId=10156&articleId=300858&version=1.0. Accessed: January 3, 2013.
76. World Tourism Organization UNWTO. Tourism highlights.2012 Edition.
77. th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISWTBE). Ticks Tick Borne Dis 2012; 3:197-201.
78. Tick-Borne Encephalitis Among US; Centers for Disease Control and Prevention (CDC). Tick-borne encephalitis among U.S. travelers to Europe and Asia - 2000-2009. MMWR Morb Mortal Wkly Rep 2010; 59:335-8; PMID:20339345.
79. Kollaritsch H. TBE vaccines: immunogenicity, effectiveness and safety. TBE SAGE meeting. Geneva, 11 April 2011. Available at: http://www.who.int/ immunization/sage/SAGE-April-2011-tbe-Kollaritsch.pdf Accessed: January 3, 2013.
80. Barrett PN, Schober-Bendixen S, Ehrlich HJ. History of TBE vaccines. Vaccine 2003; 21(Suppl 1):S41-9; PMID:12628813; http://dx.doi.org/10.1016/S0264- 410X(02)00814-9.
81. Kunz C, Hofmann H, Stary A. Field studies with a new tick-borne encephalitis (TBE) vaccine. Zentralbl Bakteriol Orig A 1976; 234:141-4; PMID:1258565.
82. Zent O, Bröker M. Tick-borne encephalitis vaccines: past and present. Expert Rev Vaccines 2005; 4:747-55; PMID:16221075; http://dx.doi.org/ 10.1586/14760584.4.5.747.
83. Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, et al. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum Vaccin 2009; 5:551-6; PMID:19430202; http://dx.doi.org/10.4161/hv.5.8.8571.
84. Wittermann C, Schöndorf I, Gniel D. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine 2009; 27:1661-6; PMID:18940221; http://dx.doi.org/10.1016/j.vaccine.2008.10.003.
85. Ehrlich HJ, Pavlova BG, Fritsch S, Poellabauer EM, Loew-Baselli A, Obermann-Slupetzky O, et al. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine 2003; 22:217-23; PMID:14615149; http://dx.doi.org/10. 1016/S0264-410X(03)00563-2.
86. Loew-Baselli A, Konior R, Pavlova BG, Fritsch S, Poellabauer E, Maritsch F, et al.; FSME-IMMUN study group. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine 2006; 24:5256-63; PMID:16624457; http://dx.doi.org/10. 1016/j.vaccine.2006.03.061.
87. Ehrlich HJ, Loew-Baselli A, Poellabauer EM, Fritsch S, Mai I, Pavlova BG, et al. Randomized, phase II, multicenter dose-finding studies of a modified tick-borne encephalitis vaccine in children: evaluation of safety and immunogenicity of two vaccinations with FSME-Immun® new. Int J Med Microbiol 2004; 293(Suppl 37):126-7.
88. Pöllabauer EM, Pavlova BG, Löw-Baselli A, Fritsch S, Prymula R, Angermayr R, et al. Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine 2010; 28:4680-5; PMID:20433803; http://dx.doi.org/10.1016/j.vaccine.2010.04.047.
89. Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Firth C, Petermann R, et al. Prevention of tickborne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme. Vaccine 2011; 29:7307-19; PMID:21843576; http://dx.doi.org/10.1016/j.vaccine.2011.07.089.
90. Loew-Baselli A, Poellabauer EM, Fritsch S, Koska M, Vartian N, Himly C, et al. Immunogenicity and safety of FSME-IMMUN 0.5 ml using a rapid immunization schedule. Int J Med Microbiol 2006; 296(Suppl 1):213-4; http://dx.doi.org/10. 1016/j.ijmm.2006.01.019.
91. Schöndorf I, Beran J, Cizkova D, Lesna V, Banzhoff A, Zent O. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 2007; 25:1470-5; PMID:17196713; http://dx.doi.org/10.1016/j.vaccine.2006.10.028.
92. Kollaritsch H, Paulke-Korinek M, Holzmann H, Hombach J, Bjorvatn B, Barrett A. Vaccines and vaccination against tick-borne encephalitis. Expert Rev Vaccines 2012; 11:1103-19; PMID:23151167; http://dx.doi.org/10.1586/erv.12.86.
93. Zent O, Banzhoff A, Hilbert AK, Meriste S, Słuzewski W, Wittermann Ch. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 2003; 21:3584-92; PMID:12922086; http://dx.doi.org/10.1016/S0264-410X(03)00421-3.
94. Plentz A, Jilg W, Schwarz TF, Kuhr HB, Zent O. Longterm persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults. Vaccine 2009; 27:853-6; PMID:19071180; http://dx.doi.org/ 10.1016/j.vaccine.2008.11.082.
95. Zent O, Beran J, Jilg W, Mach T, Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 2003; 21:738-41; PMID:12531352; http://dx.doi.org/10.1016/S0264-410X(02) 00592-3.
96. Schoendorf I, Ternak G, Oroszlàn G, Nicolay U, Banzhoff A, Zent O. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccin 2007; 3:42-7; PMID:17297298; http://dx.doi.org/10.4161/hv.3.2.3747.
97. Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, et al. Persistence of protective immunity following vaccination against tick-borne encephalitis - longer than expected? Vaccine 2004; 22:2743-9; PMID:15246606; http://dx.doi.org/10.1016/j.vaccine.2004.01.041.
98. Prymula R, Pöllabauer EM, Pavlova BG, Löw-Baselli A, Fritsch S, Angermayr R, et al. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior. Hum Vaccin Immunother 2012; 8:736-42; PMID:22699436; http://dx.doi.org/10.4161/hv.20058.
99. Lehrer AT, Holbrook MR. Tick-Borne Encephalitis. In: Barrett AT and Stanberry LR, eds. Vaccines for biodefense and emerging and neglected diseases. First edition. London: Academic Press Inc, 2009:726.
100. Ecker M, Allison SL, Meixner T, Heinz FX. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 1999; 80:179-85; PMID:9934700.
101. Leonova GN, Ternovoi VA, Pavlenko EV, Maistrovskaya OS, Protopopova EV, Loktev VB. Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus. Vaccine 2007; 25:895-901; PMID:17011677; http://dx.doi.org/10.1016/j.vaccine.2006.09.014.
102. Barret PN, Plotkin SA, Ehrlich HJ. Tick-borne encephalitis virus vaccines. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. Fifth edition. Philadelphia: Saunders, 2008:841-856.
103. Holzmann H, Vorobyova MS, Ladyzhenskaya IP, Ferenczi E, Kundi M, Kunz C, et al. Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine 1992; 10:345-9; PMID:1574920; http://dx.doi.org/10.1016/0264-410X(92)90376-U.
104. Chiba N, Osada M, Komoro K, Mizutani T, Kariwa H, Takashima I. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 1999; 17:1532-9; PMID:10195790; http://dx.doi.org/10.1016/ S0264-410X(98)00360-0.
105. Fritz R, Orlinger KK, Hofmeister Y, Janecki K, Traweger A, Perez-Burgos L, et al. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine 2012; 30:1165-9; PMID:22178103; http://dx.doi.org/10.1016/j.vaccine. 2011.12.013.
106. Hayasaka D, Goto A, Yoshii K, Mizutani T, Kariwa H, Takashima I. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains. Vaccine 2001; 19:4774-9; PMID:11535329; http://dx.doi.org/10.1016/S0264-410X(01)00218-3.
107. Leonova GN, Pavlenko EV. Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine 2009; 27:2899-904; PMID:19366574; http://dx.doi.org/10.1016/j.vaccine.2009.02.069.
108. Orlinger KK, Hofmeister Y, Fritz R, Holzer GW, Falkner FG, Unger B, et al. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans. J Infect Dis 2011; 203:1556-64; PMID:21592984; http://dx.doi.org/10.1093/infdis/ jir122.
109. Prevention of TBE, European Centre for Disease Prevention and Control (ECDC). Available at: http://ecdc.europa.eu/en/healthtopics/tick-borne-diseases/ tick-borne-encephalitis/key-messages/Pages/prevention.aspx. Accessed: January 3, 2013.
110. Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007; 25:7559-67; PMID:17869389; http://dx.doi.org/10.1016/j.vaccine.2007.08.024.
111. Kunze U. Tick-borne encephalitis: from epidemiology to vaccination recommendations in 2007. New issues - best practices. Wien Med Wochenschr 2007; 157:228-32; PMID:17564770; http://dx.doi.org/10.1007/s10354-007-0424-8.
112. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, et al. Vaccination and Tickborne Encephalitis, Central Europe. Emerg Infect Dis 2013; 19:69-76; PMID:23259984; http://dx.doi.org/10.3201/eid1901.120458.
113. Šmit R. Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults. Vaccine 2012; 30:6301-6; PMID:22885012; http://dx.doi.org/10.1016/j.vaccine.2012.07.083.
114. Schwarz B. Health economics of early summer meningoencephalitis in Austria. Effects of a vaccination campaign 1981 to 1990. Wien Med Wochenschr 1993; 143:551-5; PMID:8147001.
115. th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Vaccine 2011; 29:1355-6; PMID:21199705; http://dx.doi.org/10.1016/j.vaccine.2010.12.048.
116. Who Publication. Vaccines against tick-borne encephalitis: WHO position paper - recommendations. Vaccine 2011; 29:8769-70; PMID:21777636; http://dx.doi.org/10.1016/j.vaccine.2011.07.024.